Use of antivascular endothelial growth factor for diabetic macular edema
Rushmia Karim, Benjamin TangUniversity of Sydney School of Public Health, Concord Repatriation General Hospital, Concord, NSW, AustraliaBackground: Diabetic macular edema (DME) is one of the manifestations of diabetic retinopathy leading to loss of central vision and visual acuity. It manifests itse...
Saved in:
Main Authors: | Rushmia Karim, Benjamin Tang |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/32004324bf97400d931336fc3bc2f35c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiangiogenic drugs in the management of ocular diseases: Focus on antivascular endothelial growth factor
by: Yukio Sassa, et al.
Published: (2010) -
Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy
by: Carreras A, et al.
Published: (2012) -
Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
by: Kiss S, et al.
Published: (2014) -
Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion
by: Fujikawa M, et al.
Published: (2013) -
Topical nepafenac in the treatment of diabetic macular edema
by: David Callanan, et al.
Published: (2008)